276 related articles for article (PubMed ID: 20309398)
1. Combination of calcipotriol and methotrexate in nanostructured lipid carriers for topical delivery.
Lin YK; Huang ZR; Zhuo RZ; Fang JY
Int J Nanomedicine; 2010 Mar; 5():117-28. PubMed ID: 20309398
[TBL] [Abstract][Full Text] [Related]
2. A new topical formulation for psoriasis: development of methotrexate-loaded nanostructured lipid carriers.
Pinto MF; Moura CC; Nunes C; Segundo MA; Costa Lima SA; Reis S
Int J Pharm; 2014 Dec; 477(1-2):519-26. PubMed ID: 25445970
[TBL] [Abstract][Full Text] [Related]
3. Lipid nanoparticles as vehicles for topical psoralen delivery: solid lipid nanoparticles (SLN) versus nanostructured lipid carriers (NLC).
Fang JY; Fang CL; Liu CH; Su YH
Eur J Pharm Biopharm; 2008 Oct; 70(2):633-40. PubMed ID: 18577447
[TBL] [Abstract][Full Text] [Related]
4. Nanostructured lipid carrier mediates effective delivery of methotrexate to induce apoptosis of rheumatoid arthritis via NF-κB and FOXO1.
Garg NK; Tyagi RK; Singh B; Sharma G; Nirbhavane P; Kushwah V; Jain S; Katare OP
Int J Pharm; 2016 Feb; 499(1-2):301-320. PubMed ID: 26768725
[TBL] [Abstract][Full Text] [Related]
5. Podophyllotoxin-Loaded Nanostructured Lipid Carriers for Skin Targeting: In Vitro and In Vivo Studies.
Zhao J; Piao X; Shi X; Si A; Zhang Y; Feng N
Molecules; 2016 Nov; 21(11):. PubMed ID: 27869698
[TBL] [Abstract][Full Text] [Related]
6. Enhanced skin permeation using polyarginine modified nanostructured lipid carriers.
Shah PP; Desai PR; Channer D; Singh M
J Control Release; 2012 Aug; 161(3):735-45. PubMed ID: 22617521
[TBL] [Abstract][Full Text] [Related]
7. Design, characterization and skin permeating potential of Fluocinolone acetonide loaded nanostructured lipid carriers for topical treatment of psoriasis.
Pradhan M; Singh D; Murthy SN; Singh MR
Steroids; 2015 Sep; 101():56-63. PubMed ID: 26049018
[TBL] [Abstract][Full Text] [Related]
8. Preparation and characterization of dutasteride-loaded nanostructured lipid carriers coated with stearic acid-chitosan oligomer for topical delivery.
Noor NM; Sheikh K; Somavarapu S; Taylor KMG
Eur J Pharm Biopharm; 2017 Aug; 117():372-384. PubMed ID: 28412472
[TBL] [Abstract][Full Text] [Related]
9. Formulation, characterization, and evaluation of in vitro skin permeation and in vivo pharmacodynamics of surface-charged tripterine-loaded nanostructured lipid carriers.
Chen Y; Zhou L; Yuan L; Zhang ZH; Liu X; Wu Q
Int J Nanomedicine; 2012; 7():3023-32. PubMed ID: 22787398
[TBL] [Abstract][Full Text] [Related]
10. Preparation and Characterization of Nanostructured Lipid Carriers for Improved Topical Drug Delivery: Evaluation in Cutaneous Leishmaniasis and Vaginal Candidiasis Animal Models.
Riaz A; Hendricks S; Elbrink K; Guy C; Maes L; Ahmed N; Kiekens F; Khan GM
AAPS PharmSciTech; 2020 Jul; 21(5):185. PubMed ID: 32632542
[TBL] [Abstract][Full Text] [Related]
11. Calcipotriol delivery into the skin with PEGylated liposomes.
Knudsen NØ; Rønholt S; Salte RD; Jorgensen L; Thormann T; Basse LH; Hansen J; Frokjaer S; Foged C
Eur J Pharm Biopharm; 2012 Aug; 81(3):532-9. PubMed ID: 22538098
[TBL] [Abstract][Full Text] [Related]
12. Methotrexate loaded lipid nanoparticles for topical management of skin-related diseases: Design, characterization and skin permeation potential.
Ferreira M; Silva E; Barreiros L; Segundo MA; Costa Lima SA; Reis S
Int J Pharm; 2016 Oct; 512(1):14-21. PubMed ID: 27530292
[TBL] [Abstract][Full Text] [Related]
13. Development of a quercetin-loaded nanostructured lipid carrier formulation for topical delivery.
Chen-yu G; Chun-fen Y; Qi-lu L; Qi T; Yan-wei X; Wei-na L; Guang-xi Z
Int J Pharm; 2012 Jul; 430(1-2):292-8. PubMed ID: 22486962
[TBL] [Abstract][Full Text] [Related]
14. Design and evaluation of lidocaine- and prilocaine-coloaded nanoparticulate drug delivery systems for topical anesthetic analgesic therapy: a comparison between solid lipid nanoparticles and nanostructured lipid carriers.
You P; Yuan R; Chen C
Drug Des Devel Ther; 2017; 11():2743-2752. PubMed ID: 29075099
[TBL] [Abstract][Full Text] [Related]
15. Dithranol-loaded nanostructured lipid carrier-based gel ameliorate psoriasis in imiquimod-induced mice psoriatic plaque model.
Sathe P; Saka R; Kommineni N; Raza K; Khan W
Drug Dev Ind Pharm; 2019 May; 45(5):826-838. PubMed ID: 30764674
[TBL] [Abstract][Full Text] [Related]
16. Design and optimization of topical methotrexate loaded niosomes for enhanced management of psoriasis: application of Box-Behnken design, in-vitro evaluation and in-vivo skin deposition study.
Abdelbary AA; AbouGhaly MH
Int J Pharm; 2015 May; 485(1-2):235-43. PubMed ID: 25773359
[TBL] [Abstract][Full Text] [Related]
17. Carbomer gel bearing methotrexate loaded lipid nanocontainers shows improved topical delivery intended for effective management of psoriasis.
Tripathi P; Kumar A; Jain PK; Patel JR
Int J Biol Macromol; 2018 Dec; 120(Pt A):1322-1334. PubMed ID: 30171962
[TBL] [Abstract][Full Text] [Related]
18. In vitro characterization and growth inhibition effect of nanostructured lipid carriers for controlled delivery of methotrexate.
Abdelbary G; Haider M
Pharm Dev Technol; 2013; 18(5):1159-68. PubMed ID: 21958084
[TBL] [Abstract][Full Text] [Related]
19. Impact of nanostructured lipid carriers on dapsone delivery to the skin: in vitro and in vivo studies.
Elmowafy M; Shalaby K; Ali HM; Alruwaili NK; Salama A; Ibrahim MF; Akl MA; Ahmed TA
Int J Pharm; 2019 Dec; 572():118781. PubMed ID: 31715347
[TBL] [Abstract][Full Text] [Related]
20. Development and evaluation of nanostructured lipid carrier-based hydrogel for topical delivery of 5-fluorouracil.
Rajinikanth PS; Chellian J
Int J Nanomedicine; 2016; 11():5067-5077. PubMed ID: 27785014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]